APA (7th ed.) Citation

Roze Isono-Taniguchi, Mayako Goto, Yumi Takimoto, Tomoko Ueda, Yu Wakimoto, Kayo Inoue, . . . Hiroshi Tsubamoto. (2022). Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study. Elsevier.

Chicago Style (17th ed.) Citation

Roze Isono-Taniguchi, Mayako Goto, Yumi Takimoto, Tomoko Ueda, Yu Wakimoto, Kayo Inoue, Kensuke Hori, Kimihiko Ito, and Hiroshi Tsubamoto. Metronomic Chemotherapy Using Oral Cyclophosphamide and Bevacizumab for Recurrent Cervical Cancer: A Multi-institutional Retrospective Study. Elsevier, 2022.

MLA (9th ed.) Citation

Roze Isono-Taniguchi, et al. Metronomic Chemotherapy Using Oral Cyclophosphamide and Bevacizumab for Recurrent Cervical Cancer: A Multi-institutional Retrospective Study. Elsevier, 2022.